Ole Elvang Jensen

Placeholder Person Graphic
Jensen has spent more than two decades developing manufacturing processes for therapeutic proteins as a research scientist at Novo Nordisk. His work has played a key role in bringing drug substances forward for clinical trials. Jensen holds a master of science in organic chemistry from Aarhus University in Aarhus, Denmark; his core specialties include chromatography, ultrafiltration, and enzyme reactions. He is a published industry author.

Related Articles

Article
Technical
Evaluating In-line Volume Reduction During mAb Production

In-line concentration solves problems found in mAb production, including insufficient storage capacity and process tank volumes, extended processing times, and large hold-up loop volumes for ultrafiltration concentration. It optimizes the ion-exchange step following capture, reduces costs and processing times for virus filtration and polishing, and significantly improves the...